TScan Therapeutics to Participate in Upcoming Investor Conferences
(NASDAQ:TCRX) WALTHAM, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR...
11 days ago